随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
Lex: FT's flagship investment column
Мощный удар Израиля по Ирану попал на видео09:41，详情可参考safew官方版本下载
Дания захотела отказать в убежище украинцам призывного возраста09:44
，这一点在旺商聊官方下载中也有详细论述
When another data point is inserted and the Voronoi diagram reconstructed, the newly created region displaces the area that once belonged to the old regions. Those points whose regions were displaced are considered natural neighbours to the new point. The weight of each natural neighbour is given by the area taken from the total area occupied by the new region. In 3D, we measure polyhedral volumes instead of areas.
Последние новости，更多细节参见夫子